Exact FDA event identifier

Event 91952

17 recalled-product records grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 23, 2023
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: Preferred Pharmaceuticals, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

17 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 17

Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9

D-0511-2023

Recall number: D-0511-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 158 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot #: A0523D, Exp 5/31/2024, F14220, Exp 7/31/2023, J0622Q; Exp 1/31/2024.

Distribution pattern

USA Nationwide

drug · product 2 of 17

Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703

D-0512-2023

Recall number: D-0512-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 375 Bottles b) 323 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: B1522B, Exp 4/30/2023; lot:C0222H, C0322B, Exp 5/31/2023; lot: E1022H, F13220, H2222P, Exp 6/30/2023; Lot: I1422V, K01220, Exp 12/31/2023; Lot: L2722H, Exp 3/31/2024; b) Lot:C0322B, Exp 5/31/2023; lot:H1122G, 12322Q, Exp 6/30/2023; lot: J1222U, Exp 12/31/2023.

Distribution pattern

USA Nationwide

drug · product 3 of 17

Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9

D-0513-2023

Recall number: D-0513-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 72 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: E0922W, G1222E, I0922W and K3022W Exp 10/31/2023.

Distribution pattern

USA Nationwide

drug · product 4 of 17

Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1

D-0514-2023

Recall number: D-0514-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 3 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: H3122K, Exp 5/31/2024.

Distribution pattern

USA Nationwide

drug · product 5 of 17

Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1

D-0515-2023

Recall number: D-0515-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 4 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: L1522V, Exp 4/30/2025.

Distribution pattern

USA Nationwide

drug · product 6 of 17

Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

D-0516-2023

Recall number: D-0516-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 135 Bottles, b) 24 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: A1321V, D0221J, Exp. Date:8/31/2023; Lot: A1322J, Exp. Date: 5/31/2024; Lot: F0221Q, I0121E, I1021R, J1122D, Exp. Date: 10/31/2023; b) Lot: B0422J, Exp. Date: 5/31/2024; Lot: C1721K, Exp. Date: 8/31/2023; Lot: K1022Q, Exp. Date:11/30/2024.

Distribution pattern

USA Nationwide

drug · product 7 of 17

Glimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9

D-0517-2023

Recall number: D-0517-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 17 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: D0122K, Exp. Date: 6/30/2024; Lot: I1422N, Exp. Date: 9/30/2024; Lot: I2721B, Exp. Date: 1/31/2024.

Distribution pattern

USA Nationwide

drug · product 8 of 17

Montelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-count bottle (NDC 68788-9438-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

D-0518-2023

Recall number: D-0518-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 266 Bottles, b) not reported, c) 216 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: F3021D, Exp 12/31/2023, Lot: L0722T, Exp 5/31/2025; b) Lot: F1021I, Exp 12/31/2023; c) Lot:H1721R, Exp 12/31/2023, Lot: L0722E, Exp 5/31/2025.

Distribution pattern

USA Nationwide

drug · product 9 of 17

Rosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

D-0519-2023

Recall number: D-0519-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 59 Bottles, b) 77 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: F2022N, Exp. Date: 2/29/2024; b) Lot: F0322I, Exp. Date: 8/31/2023; Lot: J1322H, Exp. Date: 2/29/2024; Lot: K0222N, Exp. Date: 6/30/2024; Lot: L2322D and Lot: L2822J, Exp. Date:7/31/2025.

Distribution pattern

USA Nationwide

drug · product 10 of 17

Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3

D-0520-2023

Recall number: D-0520-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 264 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: A1723C, Exp 8/31/2025; Lot: A1922B, Exp 6/30/2024; Lot: D0622M and Lot: F2922I, Exp 7/31/2024; Lot: G3021L, Exp 1/31/2024; Lot:H2622P & Lot: J0722C, Exp 10/31/2024.

Distribution pattern

USA Nationwide

drug · product 11 of 17

Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8215-9

D-0521-2023

Recall number: D-0521-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 24 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: F1021I; H3122J, Exp 4/30/2024

Distribution pattern

USA Nationwide

drug · product 12 of 17

Simvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9

D-0522-2023

Recall number: D-0522-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 82 Bottles of 90 Tablets

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: C2222P, D1522L, E3122D, G2522J, Exp 9/30/2023; Lot: J1222R, Exp 10/31/2023.

Distribution pattern

USA Nationwide

drug · product 13 of 17

Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9

D-0523-2023

Recall number: D-0523-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 57 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: B0222S, Exp 2/29/2024; Lot: F1121B, G2721L, Exp 11/30/2023.

Distribution pattern

USA Nationwide

drug · product 14 of 17

Simvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-6); c) 30-count bottle (NDC 68788-9869-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.

D-0524-2023

Recall number: D-0524-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 305 Bottles, b) 72 Bottles, c) 617 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: A0923R, Exp. Date: 2/28/2025, A1222K, B1822C, Exp. Date: 5/31/2024, C3022D, F2322V, Exp. Date: 6/30/2024, H1522H, Exp. Date: 8/31/2024, I1621O, Exp. Date: 1/31/2024, I2222G, J1822R, Exp. Date: 9/30/2024, L1621N, Exp. Date: 5/31/2024; b) Lot: F0822Q, Exp. Date: 6/30/2024, I0122J, Exp. Date: 8/31/2024, L0821C, Exp. Date: 5/31/2024; c) Lot: I1521P, Exp. Date: 1/31/2024, J1322R, Exp. Date: 9/30/2024, J1821H, Exp. Date: 2/29/2024.

Distribution pattern

USA Nationwide

drug · product 15 of 17

Simvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-6); c) 30-count bottle (NDC 68788-9868-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.

D-0525-2023

Recall number: D-0525-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: a) 88 Bottles, b) 3 Bottles, c) 175 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

a) Lot: B0922G, Exp. Date: 5/31/2023, F0322G, Exp. Date: 7/25/2024, H2622M, Exp. Date: 8/31/2024, J1422B, K0722G, Exp. Date: 10/31/2024, L1922A, Exp. Date: 2/28/2025; b) Lot: F2922S, Exp. Date: 8/31/2023, H0322G Exp. Date: 7/31/2023; c) Lot: A1322I, Exp. Date: 3/31/2023, H1122C, Exp. Date: 8/31/2024.

Distribution pattern

USA Nationwide

drug · product 16 of 17

Tadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7

D-0526-2023

Recall number: D-0526-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 32 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: C0822E, Exp 1/31/2024, F1121B, Exp 1/31/2024, G2721L, Exp 1/31/2024.

Distribution pattern

USA Nationwide

drug · product 17 of 17

Glimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9

D-0527-2023

Recall number: D-0527-2023
Initiated: March 23, 2023
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 15 Bottles

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information

Lot: H1221Z, I0121J, J0622X, Exp 10/31/2023.

Distribution pattern

USA Nationwide